Ashok Venkitaraman
Fondateur chez Sentinel Oncology Ltd.
Profil
Ashok Venkitaraman is the founder of PhoreMost Ltd., a company founded in 2014 where he holds the title of Director.
Dr. Venkitaraman is also the founder of Sentinel Oncology Ltd.
Currently, Dr. Venkitaraman holds the position of Professor-Cancer Research at the University of Cambridge, is a Member of the European Molecular Biology Organization, and serves as a Strategic Advisor at Esco Ventures Pte Ltd.
In the past, Dr. Venkitaraman worked as the Director-Cancer Unit at The Medical Research Council and as a Principal at Astex Therapeutics Ltd.Dr. Venkitaraman obtained his doctorate degree from University College London.
Postes actifs de Ashok Venkitaraman
| Sociétés | Poste | Début |
|---|---|---|
Sentinel Oncology Ltd.
 Sentinel Oncology Ltd. BiotechnologyHealth Technology Sentinel Oncology Ltd. operates as a molecule drug discovery company. The firm develops and commercializes new therapeutics to treat cancer where there is an unmet medical need. The company was founded by Stuart Travers, Robert G. Boyle, Ashok Venkitaraman and Gavin Simpson in 2005 and is headquartered in Cambridge, the United Kingdom. | Fondateur | 01/01/2005 |
| University of Cambridge | Corporate Officer/Principal | - |
PhoreMost Ltd.
 PhoreMost Ltd. Pharmaceuticals: MajorHealth Technology PhoreMost Ltd. operates as a drug discovery company. It engages in identifying new druggable targets for cancer and other unmet diseases. PhoreMost uses SiteSeeker technology, a live-cell phenotypic assay system that can identify unexpected, or cryptic druggable sites in specific disease driving targets and pathways that can?t be readily seen using conventional non-cell based analytical methods. The company was founded by Christopher John Torrance and Ashok Venkitaraman on April 1, 2014 and is headquartered in Cambridge, the United Kingdom. | Fondateur | 01/01/2014 |
| European Molecular Biology Organization | Corporate Officer/Principal | - |
Esco Ventures Pte Ltd.
 Esco Ventures Pte Ltd. Investment ManagersFinance Esco Ventures Pte Ltd (Esco Ventures) is a venture capital firm founded in 2014 by Mr. Dr Nir Arbel and XiangQian (XQ) Lin. The firm is headquartered in Singapore. | Consultant / Advisor | - |
Anciens postes connus de Ashok Venkitaraman
| Sociétés | Poste | Fin |
|---|---|---|
The Medical Research Council
 The Medical Research Council Miscellaneous Commercial ServicesCommercial Services The Medical Research Council provides human healthcare and social services. It offers funding for biomedical spectrum, fundamental lab-based science, clinical trials and all major disease areas. The company was founded in 1913 and is headquartered in Swindon, the United Kingdom. | Corporate Officer/Principal | - |
Astex Therapeutics Ltd.
 Astex Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Astex Therapeutics Ltd. engages in the provision of drug discovery and development activities. Its proprietary fragment-based drug discovery platform, Pyramid, delivers drug leads on therapeutic targets and disease areas.The company was founded by Harren Jhotin, Roberto Solari, Stephen W. Bunting, Christopher Abell, and Thomas L. Blundell in 1999 and is headquartered in Cambridge, the United Kingdom. | Corporate Officer/Principal | - |
Formation de Ashok Venkitaraman
| University College London | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Sentinel Oncology Ltd.
Sentinel Oncology Ltd. BiotechnologyHealth Technology Sentinel Oncology Ltd. operates as a molecule drug discovery company. The firm develops and commercializes new therapeutics to treat cancer where there is an unmet medical need. The company was founded by Stuart Travers, Robert G. Boyle, Ashok Venkitaraman and Gavin Simpson in 2005 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Astex Therapeutics Ltd.
Astex Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Astex Therapeutics Ltd. engages in the provision of drug discovery and development activities. Its proprietary fragment-based drug discovery platform, Pyramid, delivers drug leads on therapeutic targets and disease areas.The company was founded by Harren Jhotin, Roberto Solari, Stephen W. Bunting, Christopher Abell, and Thomas L. Blundell in 1999 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
PhoreMost Ltd.
PhoreMost Ltd. Pharmaceuticals: MajorHealth Technology PhoreMost Ltd. operates as a drug discovery company. It engages in identifying new druggable targets for cancer and other unmet diseases. PhoreMost uses SiteSeeker technology, a live-cell phenotypic assay system that can identify unexpected, or cryptic druggable sites in specific disease driving targets and pathways that can?t be readily seen using conventional non-cell based analytical methods. The company was founded by Christopher John Torrance and Ashok Venkitaraman on April 1, 2014 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
The Medical Research Council
The Medical Research Council Miscellaneous Commercial ServicesCommercial Services The Medical Research Council provides human healthcare and social services. It offers funding for biomedical spectrum, fundamental lab-based science, clinical trials and all major disease areas. The company was founded in 1913 and is headquartered in Swindon, the United Kingdom. | Commercial Services |
| European Molecular Biology Organization | |
Esco Ventures Pte Ltd.
Esco Ventures Pte Ltd. Investment ManagersFinance Esco Ventures Pte Ltd (Esco Ventures) is a venture capital firm founded in 2014 by Mr. Dr Nir Arbel and XiangQian (XQ) Lin. The firm is headquartered in Singapore. | Finance |
